Annual Drug Patent Expirations for XEGLYZE
Xeglyze is a drug marketed by Hatchtech and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has thirty-two patent family members in fifteen countries.
The generic ingredient in XEGLYZE is abametapir. One supplier is listed for this compound. Additional details are available on the abametapir profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com